We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




3D Printing Used to Create Degradable Microfluidic Devices

By LabMedica International staff writers
Posted on 21 Sep 2017
A team of bioengineers modified the stereolithographic three-dimensional printing technique to create a series of microfluidic devices from biocompatible and degradable materials.

The stereolithographic technique is based on a computer-guided ultraviolet laser that traces patterns across the surface of a photoactive polymer solution. More...
The light causes the polymers to coalesce, forming covalently bound, solid three-dimensional structures within the solution. The tracing process is repeated until an entire object is built from the bottom up.

Investigators at Brown University (Providence, RI, USA) modified this technique by printing on hydrogels using noncovalent (ionic) crosslinking, which enabled reversible patterning with controlled degradation. They demonstrated the feasibility of this approach using sodium alginate, photoacid generators, and various combinations of divalent cation salts, which could be used to tune the hydrogel degradation kinetics, pattern fidelity, and mechanical properties.

The investigators described in the September 5, 2017, online edition of the journal Lab on a Chip how they used this technique to prepare template perfusable microfluidic channels within a second encapsulating hydrogel for T-junction and gradient devices. Degradable alginate barriers were used to direct collective cell migration from different initial geometries, revealing differences in front speed and leader cell formation. The presence and degradation of printed alginate microstructures were further verified to have minimal toxicity on epithelial cells.

"The idea is that the attachments between polymers should come apart when the ions are removed, which we can do by adding a chelating agent that grabs all the ions," said senior author Dr. Ian Wong, assistant professor of engineering at Brown University. "This way we can pattern transient structures that dissolve away when we want them to. We can start to think about using this in artificial tissues where you might want channels running through it that mimic blood vessels. We could potentially template that vasculature using alginate and then dissolve it away like we did for the microfluidic channels."

Related Links:
Brown University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Steam Sterilizer
Hi Vac II Line
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: New findings demonstrate that anti-Müllerian hormone (AMH) may help identify which breast cancer patients are most likely to benefit from chemotherapy plus endocrine therapy (Image Credit: Shutterstock)

AMH Test Helps Predict Adjuvant Chemotherapy Benefit in Premenopausal Breast Cancer

Hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer can present a difficult treatment decision in premenopausal patients with low recurrence scores.... Read more

Molecular Diagnostics

view channel
Image Credit: iStock

Sequencing-Based Newborn Screening Identifies Pediatric Cancer Risk at Birth

Newborn screening in the United States relies on heel-stick blood spots to identify rare, treatable disorders through biochemical testing, but these programs generally do not assess inherited cancer risk... Read more

Microbiology

view channel
Image: The QIAstat-Dx BCID GPF Plus AMR Panel is the first QIAstat-Dx panel for bloodstream infections to receive FDA clearance (Photo courtesy of Qiagen)

FDA Clears One-Hour Panel for Bloodstream Infection and AMR Detection

Bloodstream infections can rapidly progress to sepsis, a life-threatening condition affecting an estimated 1.7 million adults in the U.S. each year. Rapid identification of pathogens and antimicrobial... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.